Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: Elanco | Vintage Vibes

Insiders Are Betting Big on These 3 Healthcare Stocks

Insiders are buying shares of Braveheart Bio, BlossomHill Therapeutics and Elanco, three health care stocks with differing risk profiles, analyst ratings, and pipeline catalysts ahead.

MarketBeat · Aug 31

FDA Authorizes an Emergency Preventive Drug for New World Screwworm in Cattle, Sheep, Goats and Swine

FDA Authorizes an Emergency Preventive Drug for New World Screwworm in Cattle, Sheep, Goats and Swine

The FDA authorized CLiK Extra wound spray to prevent New World screwworm in livestock. The parasite rarely reaches humans through open wounds.

Medical Daily · Aug 10

Elanco Shares Poised For Upside After Another Quarter Of Outperformance

Elanco Shares Poised For Upside After Another Quarter Of Outperformance

Elanco Animal Health Incorporated (NYSE:ELAN) reported third-quarter 2025 results on Wednesday, posting adjusted earnings per share of 19 cents, up 46% year over year.

Benzinga · Nov 5, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook

Elanco Animal Health Incorporated (NYSE:ELAN) reported second-quarter 2025 results on Thursday, posting adjusted earnings per share of 26 cents, down 13% year over year.

Benzinga · Aug 7, 2025

Must we give up meat to save the planet? Maybe not

"The cow is the how."

Fortune · Nov 2, 2023

Elanco Animal Health Cuts FY22 Guidance After Q1 Earnings Beat Expectations Marginally

Elanco Animal Health Inc (NYSE:ELAN) has reported a Q1 EPS of $0.36, lower than the $0.37 reported a year ago, surpassing analysts' view of $0.35. Revenue was $1.225 billion, a decrease of 1% YY, slightly above the consensus of $1.22 billion. Pet Health's revenue decreased by 1% and was up 2% when excluding…

Benzinga · May 9, 2022

Elanco, Ginkgo Bioworks Launch BiomEdit, Microbiome-Focused Animal Health Firm

Elanco Animal Health Incorporated (NYSE:ELAN) and Ginkgo Bioworks Holdings Inc (NYSE:DNA) have launched BiomEdit, a microbiome innovation company. BiomEdit will discover, develop and introduce novel probiotics, bioactive molecules, engineered microbial medicines, and microbial monitoring services for animal health. In October last year, Elanco announced its intention to carve out its microbiome platform and pipeline under the leadership…

Benzinga · Apr 11, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

Elanco Animal Health's Q4 Earnings Beat Expectation, FY22 Sales Guidance Trail Estimates

Elanco Animal Health's Q4 Earnings Beat Expectation, FY22 Sales Guidance Trail Estimates

Elanco Animal Health Inc (NYSE: ELAN) has reported

Benzinga · Feb 24, 2022

Elanco's Long-Acting Transdermal Buprenorphine for Cats Gains FDA Approval

Elanco's Long-Acting Transdermal Buprenorphine for Cats Gains FDA Approval

Benzinga · Jan 21, 2022

1

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Ginkgo Bioworks Holdings Inc

Elanco Animal Health

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

420,238 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play